A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).
<h4>Background</h4>There have been increasing concerns regarding the safety and efficacy of neuroleptics in people with dementia, but there are very few long-term trials to inform clinical practice. The aim of this study was to determine the impact of long-term treatment with neuroleptic...
Guardado en:
Autores principales: | Clive Ballard, Marisa Margallo Lana, Megan Theodoulou, Simon Douglas, Rupert McShane, Robin Jacoby, Katja Kossakowski, Ly-Mee Yu, Edmund Juszczak, Investigators DART AD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/119aea6129014cfcb7554b21bfb5278c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of neurolept-induced tardive dyskinesia
por: Jankelowitz SK
Publicado: (2013) -
Professor Raymond Dart
por: J. D. Verster
Publicado: (1961) -
Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis
por: Ueda S, et al.
Publicado: (2016) -
Neuroleptic malignant syndrome: an easily overlooked neurologic emergency
por: Oruch R, et al.
Publicado: (2017) -
Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
por: Miguel Santos, et al.
Publicado: (2021)